Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis

Stefanie C Fas1, Sven Baumann, Jia Yun Zhu

  • 1Tumor Immunology Program D030, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Blood
|August 26, 2006
PubMed

Insights

Wogonin, a herbal compound, enhances tumor cell killing by sensitizing leukemia cells to TNFalpha-induced apoptosis. This natural adjuvant shows promise for cancer therapy with reduced side effects compared to conventional treatments.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Tumor Necrosis Factor alpha (TNFalpha) has shown anticancer potential but is limited by toxicity and activation of pro-inflammatory NF-kappaB pathways.
  • Current in vitro methods to enhance TNFalpha efficacy involve toxic inhibitors with harmful in vivo side effects.

Purpose of the Study:

  • To investigate wogonin, a compound from Huang-Qin, as a potential adjuvant to enhance TNFalpha and TRAIL-induced cancer cell apoptosis.
  • To evaluate wogonin's mechanism in sensitizing TNFalpha-resistant cells and its safety profile on normal cells.

Main Methods:

  • Assessed wogonin's effect on NF-kappaB activity and TNFalpha-induced apoptosis in leukemia cells.
  • Investigated the role of reactive oxygen species (ROS) modulation, specifically the shift from superoxide radical (.O(2)(-)) to hydrogen peroxide (H(2)O(2)).
  • Evaluated wogonin's impact on the viability of normal peripheral blood T cells and its effect on TRAIL-induced apoptosis.

Main Results:

  • Wogonin attenuates NF-kappaB activity by altering TNFalpha-induced free radical (.O(2)(-)) to H(2)O(2), sensitizing resistant leukemia cells to apoptosis.
  • Wogonin demonstrated selectivity, not affecting the viability of normal T cells.
  • Wogonin also enhanced apoptosis induced by TRAIL (TNF-related apoptosis-inducing ligand).

Conclusions:

  • Wogonin acts as a potent adjuvant, enhancing TNFalpha and TRAIL-mediated cancer cell apoptosis.
  • Wogonin offers a potentially safer alternative for cancer treatment by reducing side effects associated with conventional therapies.
  • This study highlights the therapeutic potential of herbal compounds in cancer treatment strategies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...